摘要 : BACKGROUND Human epidermal growth factor receptor-2(HER-2)plays a vital role in tumor cell proliferation and metastasis.However,the prognosis of HER2-positive gastric cancer is poor.Inetetamab,a novel anti-HER2 targeting drug inde... 展开
作者 | Jing-Hao Zhou Qi-Jun Yi Ming-Yan Li Yan Xu Qi Dong Cong-Ying Wang Hai-Yan Liu |
---|---|
作者单位 | |
期刊名称 | 《World Journal of Clinical Cases》 |
期刊英文名称 | 《世界临床病例杂志》 |
页码/总页数 | P.820-827 / 8 |
语种/中图分类号 | 汉语 / R73 |
关键词 | Inetetamab Gastric cancer Human epidermal growth factor receptor-2 protein Tegafur Case report |
DOI | 10.12998/wjcc.v12.i4.820 |
基金项目 | Supported by the Science and Technology Innovation Development Project of Tai’an,No.2021NS160;the Medical and Health Science and Technology Development Plan of Shandong Province,No.202102010647。 |